← Leaderboards
Wesley H Self
Vanderbilt University
$22,565,588
Attributed
$66,330,834
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $19.1M · FY2015–25$20M$15M$10M$5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$66,330,834 · 4
By mechanism
UL1$44,324,976 · 1
U01$16,153,090 · 1
U24$5,169,803 · 1
K23$682,965 · 1
Top collaborators
- Gordon R. Bernard8 shared
- Christopher J. Lindsell5 shared
- Consuelo Hopkins Wilkins5 shared
- Paul A. Harris1 shared
- Matthew Stephen Shotwell1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Hua Xu$24,669,289
- Paul A. Harris$96,350,527
- David K Cortez$25,955,406
- Gordon R. Bernard$207,867,283
- Walter J Chazin$29,538,014
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationClinical ResearchCommunitiesDesignMorbidity - Disease RateEnsureComplexCommunity EngagementFundingProgramsFoundationsScienceSiteOperationInfrastructureCohortPatient PopulationRecoveryPneumoniaMissionResearch InfrastructureHealthcareResearch PersonnelSkills
Grant awards (15)
Vanderbilt Institute for Clinical and Translational Research (VICTR)$10,726,281
UL1 · FY2025 · TR · contact PI
Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)$6,838,427
U01 · FY2025 · HL · contact PI
Vanderbilt Institute for Clinical and Translational Research (VICTR)$10,954,065
UL1 · FY2024 · TR · contact PI
Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)$6,593,257
U01 · FY2024 · HL · contact PI
Expediting the Sharing of APS Consortium Specimens and Data Amidst Expanded Operations$434,315
U01 · FY2024 · HL · contact PI
Vanderbilt Institute for Clinical and Translational Research (VICTR)$10,954,065
UL1 · FY2023 · TR · contact PI
Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC)$5,169,803
U24 · FY2023 · TR
Coordination for ARDS, Pneumonia, and Sepsis supporting Training, Organization and Network Efficiency (CAPSTONE)$2,287,091
U01 · FY2023 · HL · contact PI
ComPASS Collective for Community Engagement (C3E)$700,000
UL1 · FY2023 · TR · contact PI
Vanderbilt Institute for Clinical and Translational Research (VICTR)$10,990,565
UL1 · FY2022 · TR
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in Adults$172,443
K23 · FY2018 · GM · contact PI
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in Adults$170,639
K23 · FY2017 · GM · contact PI
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in Adults$155,192
K23 · FY2016 · GM · contact PI
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in Adults$13,250
K23 · FY2016 · GM · contact PI
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in Adults$171,441
K23 · FY2015 · GM · contact PI